Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2016 1
2018 2
2019 5
2020 3
2021 2
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Cell division in tissues enables macrophage infiltration.
Akhmanova M, Emtenani S, Krueger D, Gyoergy A, Guarda M, Vlasov M, Vlasov F, Akopian A, Ratheesh A, De Renzis S, Siekhaus DE. Akhmanova M, et al. Among authors: emtenani s. Science. 2022 Apr 22;376(6591):394-396. doi: 10.1126/science.abj0425. Epub 2022 Apr 21. Science. 2022. PMID: 35446632
Milestones in Personalized Medicine in Pemphigus and Pemphigoid.
Bieber K, Kridin K, Emtenani S, Boch K, Schmidt E, Ludwig RJ. Bieber K, et al. Among authors: emtenani s. Front Immunol. 2021 Jan 11;11:591971. doi: 10.3389/fimmu.2020.591971. eCollection 2020. Front Immunol. 2021. PMID: 33505392 Free PMC article. Review.
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
Ghorbanalipoor S, Emtenani S, Parker M, Kamaguchi M, Osterloh C, Pigors M, Gross N, Khil'chenko S, Kasprick A, Patzelt S, Wortmann D, Ibrahim IO, Izumi K, Goletz S, Boch K, Kalies K, Bieber K, Smith P, Schmidt E, Ludwig RJ. Ghorbanalipoor S, et al. Among authors: emtenani s. Front Immunol. 2022 Nov 30;13:1099535. doi: 10.3389/fimmu.2022.1099535. eCollection 2022. Front Immunol. 2022. PMID: 36532003 Free PMC article.
Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus.
Emtenani S, Ghorbanalipoor S, Mayer-Hain S, Kridin K, Komorowski L, Probst C, Hashimoto T, Pas HH, Męcińska-Jundziłł K, Czajkowski R, Recke A, Sunderkötter C, Schneider SW, Hundt JE, Zillikens D, Schmidt E, Ludwig RJ, Hammers CM. Emtenani S, et al. J Invest Dermatol. 2021 Dec;141(12):2820-2828. doi: 10.1016/j.jid.2021.06.007. Epub 2021 Jul 8. J Invest Dermatol. 2021. PMID: 34246620 Free article.
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
Ghorbanalipoor S, Emtenani S, Parker M, Kamaguchi M, Osterloh C, Pigors M, Gross N, Khil'chenko S, Kasprick A, Patzelt S, Wortmann D, Ibrahim IO, Izumi K, Goletz S, Boch K, Kalies K, Bieber K, Smith P, Schmidt E, Ludwig RJ. Ghorbanalipoor S, et al. Among authors: emtenani s. Front Immunol. 2022 Sep 28;13:865241. doi: 10.3389/fimmu.2022.865241. eCollection 2022. Front Immunol. 2022. PMID: 36248903 Free PMC article.
Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S, Holtsche MM, Stahlkopf R, Seiler DL, Burn T, Liu H, Parker M, Yilmaz K, Dikmen HO, Lang MH, Sadik CD, Karsten CM, van Beek N, Ludwig RJ, Köhl J, Schmidt E. Emtenani S, et al. Front Immunol. 2022 Nov 18;13:942493. doi: 10.3389/fimmu.2022.942493. eCollection 2022. Front Immunol. 2022. PMID: 36466856 Free PMC article.
21 results